Controversies in Rectal Cancer International Conference

Category: Training - School of Surgery

Date: September 4th 2012 until September 5th 2012

Location: The Postgraduate Medical Institute, Anglia Ruskin University, PMI Building Bishop Hall Lane, Chelmsford Essex CM1 1SQ

Google map


For general/colorectal surgical trainees.

In recent years the management of rectal cancer has become increasingly complex with difficult decisions to be made on imaging, surgery, radiotherapy and chemotherapy. Pathological assessment has also become more complicated. This new meeting in the UK has been developed from a very successful multi-disciplinary conference held in Sao Paulo, Brazil in alternate years and we hope it will be of interest to all – surgeons, pathologists, radiologists, oncologists and nurses - who treat patients with rectal cancer. We have attracted an international faculty covering all aspects or rectal cancer management to address the current issues facing all of us who manage this disease. To encourage multi-disciplinary teams to attend, this conference offers discounts on the registration fee for three or more delegates from the same hospital.




8.30 – 9.00 Registration and coffee

9.00 – 9.05 Opening of the meeting and Welcome - Roger Motson (UK)

9.05 – 10.30
Session 1 – Early Rectal Cancer
Chairmen - Tan Arulampalam (UK) & Corrie Marijnen (Holland)
Assessment – Ultrasound - Arun Gupta; MRI – Darren Boone (UK)
Treatment – TEM - Neil Mortensen (UK); TEO - Nick Armitage (UK)
The TREC Trial for T2N0 and T1N0 Cancer - Simon Bach (UK)

10.30 – 11.00 Coffee

11.00 – 12.30
Session 2 Radiation Therapy
Chairmen - Neil Mortensen (UK), David Tsang (UK)
Pros and cons of Short course - Corrie Marijnen (Holland)
Dose-effect relationship - Anders Jakobsen (Sweden)
Margins after Radiotherapy - Robert Glynne-Jones (UK)
Margins without Radiotherapy - Bill Heald (UK)
Scar excision after complete response, yes or no? - Emanuele Lezoche (Italy)

12.30 – 13.00
Session 3Survivorship after Surgery - Anna Wordley (UK); tbc

13.00 – 14.00 Lunch

14.00 – 15.00
Session 4 – Video session
Chairmen - Neil Mortensen (UK), Emanuele Lezoche (Italy)
Trans-anal TME with laparoscopic instrumentation – Antonio Lacy (Spain)
Inter-sphincteric dissection – Yves Panis (France)
The APPEAR Procedure - Norman Williams (UK)
Robotic TME - Mark Gudgeon (UK)

15.00 – 15.30
Session 5 Guest Lecture
Chairman - Roger Motson (UK)
Laparoscopic Surgery for Rectal Cancer – why are we waiting? - Antonio Lacy (Spain)

15.30 – 16.00 Coffee

16.00 – 17.30
Session 6 Abdomino-Perineal Excision
Chairman - Bill Heald (UK)
Abdominal Dissection – open, where to stop - Paris Tekkis (UK)
Abdominal Dissection – laparoscopic, where to stop - Amjad Parvais (UK)
Perineal Dissection – prone or supine - John Marks (USA) – Supine tbc
Pathology of Rectal Excision - Nick West (UK)

19.00 - 23.00
Reception and Dinner at Five Lakes


09.00 – 10.30
Session 7 Pre-operative Assessment and Decision Making for T2 T3 tumours
Chairman - Michael Dworkin (UK)
Clinical assessment - John Nicholls (UK)
MRI or Diffusion MRI? - Darren Boone (UK)
Oncologist involvement - David Sebag-Montefiore (UK)

10.30 – 11.00
Session 8 Guest Lecture
Chairman - Roger Motson (UK)
Wait and watch after complete clinical response - Angelita Habr-Gama (Braz11.00- 11.30 Coffee

11.30- 13.00
Session 9 When Should Surgery take place after Radiotherapy?
Chairmen - Tan Arulampalam (UK), David Tsang (UK)
Serial MRI scans - Vicky Goh (UK)
6 versus 12 trial update - Jessica Evans (UK)
Does PET-CT help to decide? - Ashley Groves (UK)
Deferral of Surgery - Diana Tait (UK)

13.00 – 14.00 Lunch

14.00 – 15.15
Session 10 Pathology, Molecular Biology and Chemotherapy
Chairman - Bruce Sizer (UK)
Time to standardise for international comparison - Nick West (UK)
Predictors of Tumour Response - Rodrigo Perez (Brazil)
Management of metastatic disease – biologic agents and how to combine them with chemotherapy - Mark Harrison (UK)
Should chemotherapy continue while waiting for surgery after neo-adjuvant chemo-radiation? - Harpreet Wasan (UK) tbc
Who should receive post-op chemotherapy folneo-adjuvant chemo-radiation? - Robert Glynne-Jones (UK)

15.15 – 16.00
Session 11 TME Robotic or Laparoscopic?
Chairman - Amjad Parvais (UK)
Robotic TME - Mark Gudgeon (UK)
Standard TME - John Marks (USA)

16.00 Close of meeting


Delegate - Early Bird Registration. Cost £300.00

Delegate – Early Bird Registration GROUP. Cost £250.00

Nurse & Allied Health Professional Early Bird Registration. Cost £100.00

Nurse & Allied Health Professional Early Bird Registration (Group). Cost £75.00

Registrars & Trainees Early Bird Registration. Cost £150.00

Registrars & Trainees Early Bird Registration (Group). Cost £120.00


GROUP rates are for 3 or more from one hospital. Anyone who uses the GROUP rate will subsequently be charged the full rate if the requirement for 3 from one hospital is not met. Early Bird Registration is until Saturday 4th August 2012


Invited Faculty

Professor Roger Motson
Professor Corrie Marijnen
Professor Conor Delaney
Professor Neil Mortensen
Mr Nicholas Armitage
Mr Simon Bach
Professor Paris Tekkis
Professor Anders Jakobsen
Professor Martin Weiser
Professor Bill Heald
Dr Emanuele Lezoche
Professor Yves Panis
Professor Antonio Lacy
Professor Norman Williams
Mr Mark Gudgeon
Professor John Nicholls
Professor David Sebag-Montefiore
Dr Jessica Evans
Dr Ashley Groves
Dr Diana Tait
Professor Eric van Cutsem
Dr Robert Glynne-Jones
Mr Tan Arulampalam
Dr Bruce Sizer
Mr Michael Dworkin
Professor Amjad Parvaiz
Mr Peter Sagar
Dr Nick West 


For more information, contact Isla Drage on 01245 686 791 or at